ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 94 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $22,349,000 | -42.3% | 5,411,414 | +13.1% | 0.00% | -50.0% |
Q3 2016 | $38,761,000 | +9.7% | 4,785,281 | +5.6% | 0.01% | 0.0% |
Q2 2016 | $35,343,000 | +0.1% | 4,531,181 | -0.9% | 0.01% | 0.0% |
Q1 2016 | $35,306,000 | -26.8% | 4,573,313 | +2.3% | 0.01% | -27.3% |
Q4 2015 | $48,244,000 | +47.8% | 4,471,134 | -5.3% | 0.01% | +37.5% |
Q3 2015 | $32,639,000 | -15.0% | 4,723,459 | +9.0% | 0.01% | -11.1% |
Q2 2015 | $38,387,000 | -14.2% | 4,332,613 | -4.5% | 0.01% | -18.2% |
Q1 2015 | $44,742,000 | -5.2% | 4,537,734 | +17.8% | 0.01% | -8.3% |
Q4 2014 | $47,178,000 | +35.6% | 3,851,254 | +10.5% | 0.01% | +20.0% |
Q3 2014 | $34,782,000 | +29.4% | 3,485,121 | -1.9% | 0.01% | +25.0% |
Q2 2014 | $26,888,000 | +125.8% | 3,551,912 | -1.9% | 0.01% | +100.0% |
Q1 2014 | $11,910,000 | +3.3% | 3,620,099 | +4.2% | 0.00% | 0.0% |
Q4 2013 | $11,531,000 | +7.7% | 3,474,382 | -2.0% | 0.00% | 0.0% |
Q3 2013 | $10,708,000 | -57.5% | 3,545,705 | +15.2% | 0.00% | -55.6% |
Q2 2013 | $25,182,000 | – | 3,078,435 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |